logo

For the Inventor, By the Inventor

Woodside, NY, United States of America

Xue-Ru Wu

This inventor holds 5 USPTO granted patents. Top assignee: New York University. Active years: 2001-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xue-Ru Wu. Retrieved from https://idiyas.com/inventor/xue-ru-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Woodside, NY (US) (2001)
  • New York, NY (US) (2001)
  • Staten Island, NY (US) (2003 - 2005)

Company Filing History:

goldMedal5 out of 1,728 
 
New York University
 patents

Years Active: 2001-2005

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6888047 - Transgenic animals as urinary bioreactors for the production of polypeptide in the urine, recombinant DNA construct for kidney-specific expression, and method of using same (2005-05-03),
2. 6632431 - Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same (2003-10-14),
3. 6323390 - Transgenic mouse models for human bladder cancer (2001-11-27),
4. 6290959 - Method for screening compounds for inhibiting bacterial attachment to host cell receptors (2001-09-18),
5. 6277968 - Human uroplakin II gene and methods for detecting and classifying bladder cancer via human uroplakin genes (2001-08-21),

Title: Innovations of Xue-Ru Wu in Bioreactor Technology

Introduction

Xue-Ru Wu is a prominent inventor based in Woodside, NY (US), known for his significant contributions to bioreactor technology. He holds a total of 5 patents that focus on innovative methods for producing biologically active proteins in non-human mammals. His work has implications for both medical and biotechnological applications.

Latest Patents

Wu's latest patents include groundbreaking inventions such as "Transgenic animals as urinary bioreactors for the production of polypeptide in the urine." This invention relates to recombinant DNA constructs and a method for producing a recombinant biologically active protein in vivo in the urine of a non-human mammal using a kidney-specific promoter. Another notable patent is "Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli." This invention focuses on an anti-idiotypic antibody or antigen-binding fragment against FimH adhesin, which is crucial for developing immunizing compositions.

Career Highlights

Xue-Ru Wu is affiliated with New York University, where he has been instrumental in advancing research in the field of bioreactor technology. His innovative approaches have garnered attention in both academic and industrial circles, contributing to the understanding of protein production in transgenic models.

Collaborations

Wu collaborates with Tung-Tien Sun, a fellow researcher who has contributed to his work in the field. Their partnership has led to advancements in the development of immunizing compositions and methods for enhancing antibody production.

Conclusion

Xue-Ru Wu's innovative work in bioreactor technology and his contributions to the field of recombinant DNA constructs highlight the potential for transgenic animals in medical applications. His patents reflect a commitment to advancing scientific knowledge and improving biotechnological processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…